WASHINGTON — The Food and Drug Administration has established the Office of Dietary Supplement Programs (ODSP), raising the program from its previous status as a division under the Office of Nutrition Labeling and Dietary Supplements. The FDA said Monday that it’s also in the process of identifying permanent leadership for ODSP. Meanwhile, Bob Durkin will
WASHINGTON — To eliminate trans fat in processed foods, the Food and Drug Administration has called on food manufacturers to remove partially hydrogenated oils (PHOs) from products over the next three years. The FDA said Tuesday that, following “a thorough review of the scientific evidence,” it has concluded that PHOs — the primary dietary source
Margaret Hamburg WASHINGTON — Margaret Hamburg reportedly is stepping down as commissioner of the Food and Drug Administration. Published reports said Thursday that the 59-year-old Hamburg is slated to leave the FDA commissioner post at the end of March and that the Obama administration plans to make a formal announcement on Friday. Plans call for
WASHINGTON — The Healthcare Distribution Management Association (HDMA) is praising the Food and Drug Administration for its flexibility pertaining to new product tracing rules, specifically on the FDA’s recently released guidance titled “Product Tracing Requirements — Compliance Policy.” The association had sent letters to the regulatory agency in November and then again last month in
WASHINGTON — A Food and Drug Administration panel has recommended that the agency approve what could become the country’s first biosimilar. The panel unanimously urged approval of Sandoz’s filgrastin (Neupogen), a cancer treatment. “This encouraging step forward means that it is very likely now only a question of when, rather than if, filgrastin will be available